We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.25%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.4B
AUM Growth
+$904M
Cap. Flow
+$84.9M
Cap. Flow %
0.49%
Top 10 Hldgs %
29.78%
Holding
722
New
36
Increased
329
Reduced
218
Closed
40

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$66.4M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$57.7M
3
AMZN icon
Amazon
AMZN
+$56.5M
4
AMD icon
Advanced Micro Devices
AMD
+$37.5M
5
CRM icon
Salesforce
CRM
+$35.5M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$122M
2
TMO icon
Thermo Fisher Scientific
TMO
+$60.8M
3
AMAT icon
Applied Materials
AMAT
+$43.7M
4
NU icon
Nu Holdings
NU
+$35.9M
5
INCY icon
Incyte
INCY
+$32.5M

Sector Composition

Rank Sector Weight
1 Technology 31.8%
2 Healthcare 28.54%
3 Financials 9.44%
4 Consumer Discretionary 7.84%
5 Industrials 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EMR icon
26
Emerson Electric
EMR
$82.9B
$114M 0.66%
1,044,167
+90,457
+9% +$9.73M
JPM icon
27
JPMorgan Chase
JPM
$939B
$114M 0.66%
541,461
+44,638
+9% +$9.4M
ISRG icon
28
Intuitive Surgical
ISRG
$121B
$113M 0.65%
230,226
-16,641
-7% -$7.75M
BNTX icon
29
BioNTech
BNTX
$22.6B
$110M 0.63%
927,164
+348,166
+60% +$32M
QCOM icon
30
Qualcomm
QCOM
$176B
$109M 0.63%
643,284
+33,642
+6% +$5.94M
ZTS icon
31
Zoetis
ZTS
$31.6B
$108M 0.62%
554,340
+183,100
+49% +$33.7M
TSLA icon
32
Tesla
TSLA
$1.24T
$104M 0.6%
399,416
-15,665
-4% -$3.57M
CDNS icon
33
Cadence Design Systems
CDNS
$90B
$103M 0.59%
379,788
+7,363
+2% +$2.04M
MELI icon
34
Mercado Libre
MELI
$91.3B
$98.1M 0.56%
47,823
-2,708
-5% -$5.1M
DHR icon
35
Danaher
DHR
$135B
$97.9M 0.56%
352,267
-57,207
-14% -$15.1M
ALNY icon
36
Alnylam Pharmaceuticals
ALNY
$36.3B
$96.7M 0.56%
351,668
+440
+0.1% +$115K
AMAT icon
37
Applied Materials
AMAT
$426B
$93.6M 0.54%
463,445
-213,111
-31% -$43.7M
HOLX
38
DELISTED
Hologic
HOLX
$92.6M 0.53%
1,137,379
-206,207
-15% -$16.5M
IQV icon
39
IQVIA
IQV
$34.7B
$92.2M 0.53%
389,000
-152
-0% -$35.9K
META icon
40
Meta Platforms (Facebook)
META
$1.51T
$91.6M 0.53%
160,100
-8,959
-5% -$4.61M
AXP icon
41
American Express
AXP
$223B
$91.2M 0.52%
336,242
-22,671
-6% -$5.65M
PGR icon
42
Progressive
PGR
$124B
$88.2M 0.51%
347,726
+4,230
+1% +$983K
ECL icon
43
Ecolab
ECL
$75.6B
$86.8M 0.5%
339,819
-26,033
-7% -$6.37M
MU icon
44
Micron Technology
MU
$1.04T
$79.1M 0.45%
763,134
-199,549
-21% -$20.9M
ON icon
45
ON Semiconductor
ON
$33.8B
$78.2M 0.45%
1,076,717
-119,913
-10% -$8.73M
MDLZ icon
46
Mondelez International
MDLZ
$77.7B
$77.3M 0.44%
1,049,736
+397,870
+61% +$28M
WCN
47
Waste Connections
WCN
$42.8B
$77.2M 0.44%
431,426
+27,920
+7% +$5.05M
ABBV icon
48
AbbVie
ABBV
$458B
$76.5M 0.44%
387,222
+154,741
+67% +$28.9M
CSCO icon
49
Cisco
CSCO
$450B
$75.1M 0.43%
1,411,131
-393,105
-22% -$19.1M
PTC icon
50
PTC
PTC
$13.7B
$74.1M 0.43%
410,401
-28,226
-6% -$4.96M
1
2
3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q3 2024 Portfolio in Review

As of Q3 2024, Candriam SCA held 722 positions worth $17.4B, up 5.5% from $16.5B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Candriam SCA's Q3 2024 filing shows 36 new, 329 increased, 218 reduced and 40 closed positions. Its largest new stake was Avidity Biosciences: 323,396 shares worth $14.9M. The largest sale was Lam Research, an estimated $122M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q3 2024 buy was Avidity Biosciences: 323,396 shares worth $14.9M.
  • Candriam SCA added most to Amgen in Q3 2024, an estimated $66.4M increase.
  • Candriam SCA's biggest Q3 2024 reduction was Thermo Fisher Scientific, cutting an estimated $60.8M.
  • Candriam SCA fully exited Lam Research in Q3 2024, selling an estimated $122M.
  • Candriam SCA's ten largest holdings make up 30% of its $17.4B portfolio in Q3 2024.
  • Candriam SCA opened 36 new positions and closed 40 in Q3 2024.
  • Candriam SCA's portfolio value rose 5.5% quarter-over-quarter to $17.4B.

Based on Candriam SCA's 13F filing for Q3 2024, filed 13 Nov 2024.